Cingulate Inc.
Key Metrics
Market Snapshot
About
Cingulate Inc. is a biopharmaceutical company focused on developing treatments for attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. The company's lead product candidate uses a proprietary drug delivery technology called Precision Timed Release (PTR) to provide improved pharmacokinetic profiles for stimulant medications. Headquartered in Kansas City, Missouri, Cingulate aims to address limitations of existing ADHD treatments by offering more consistent medication delivery throughout the day. The company is conducting clinical trials to advance its product candidates through regulatory approval processes.